{
    "clinical_study": {
        "@rank": "88885", 
        "arm_group": [
            {
                "arm_group_label": "A) TEST", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "B) CONTROL", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "This study will compare the efficacy and safety of Extended Release Tacrolimus (Advagraf\u00ae) +\n      Sirolimus (Rapamune\u00ae), versus Extended Release Tacrolimus (Advagraf\u00ae) + Mycophenolate\n      mofetil in Kidney Transplant Patients."
        }, 
        "brief_title": "Study to Evaluate the Safety and Efficacy of Extended Release Tacrolimus (Advagraf\u00ae) + Sirolimus (Rapamune\u00ae), Versus Extended Release Tacrolimus (Advagraf\u00ae) + Mycophenolate Mofetil in Kidney Transplant Patients", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Kidney Transplant Patients", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female patients aged over 20 years\n\n          -  Patient who is judged would have the benefits of the Extended Release\n             Tacrolimus (Advagraf\u00ae)treatment by the investigator\n\n          -  Patients has given written informed consent\n\n          -  Patient is a recipient of primary or recipient of primary (a living kidney\n             transplant, a cadaveric donor.)\n\n          -  Patients has received an ABO compatible donor kidney.\n\n          -  Complement-dependent Cytotoxic Crossmatch: CDC) result: negative\n\n          -  Female patients of child bearing potential must have a negative urine or serum\n             pregnancy test within 7 days prior to enrollment or upon hospitalization\n\n        Exclusion Criteria:\n\n          -  Patient has previously received an organ transplant other than a kidney.\n\n          -  Patient has a known hypersensitivity to tacrolimus, Sirolimus\n             (Rapamune\u00ae),Mycophenolate mofetil.\n\n          -  Desensitization\n\n          -  HLA-identical\n\n          -  Heart Disease; Heart failure (symptom, EF <45%)\n\n          -  Lung Disease; Significant chronic obstructive pulmonary disease, restrictive lung\n             disease\n\n          -  Patient has an uncontrolled concomitant infection (including Hepatitis B, Hepatitis\n             C) or any other unstable\n\n          -  malignant tumor history in the 5years prior to enrollment. (except,squamous cell\n             carcinoma)\n\n          -  Patient has received a kidney transplant from non-heart beating donor\n\n          -  Cold ischemic time > 30hrs\n\n          -  Elevated AST and/or ALT levels greater than 3 times the upper value of the normal\n             range of the investigational site\n\n          -  (ANC)<1,500/mm3, (WBC)<2,500/ mm3, (PLT)<100,000/ mm3\n\n          -  ATG: Anti-thymocyte globulin induction\n\n          -  Medical condition that could interfere with the study objectives.\n\n          -  Patient is currently taking or has been taking an investigational products in the 30\n             days prior to enrollment.\n\n          -  Patient is currently taking or has been taking an prohibited medications in the 28\n             days prior to enrollment.\n\n          -  Patient who is judged not to be adequate by the investigator owing to other reasons\n\n          -  Patient is pregnant or lactating.\n\n          -  Recipient or donor is known to be seropositive for human immunodeficiency virus.(HIV)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 4, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01680952", 
            "org_study_id": "4-2011-0920"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "A) TEST", 
                    "B) CONTROL"
                ], 
                "description": "Extended Release Tacrolimus (Advagraf\u00ae)\n\u2460 Living The day before surgery: 0.2 mg/kg(morning dose) po, qd Morning on the day of surgery:  0.1 mg/kg po, qd After surgery, the capacity is adjusted according to the trough level. clinical significance, electrolyte level.\n\u2461 Cadaveric Before surgery at once : 0.1 mg/kg within 12hours before surgery. After surgery : 0.2mg/kg po. in the morning After that, the capacity is adjusted according to the trough level. clinical significance, electrolyte level.\nSirolimus (Rapamune\u00ae):\nAfter surgery : 2mg/kg po. within 24hrs after reperfusion. After that, the capacity is adjusted according to the trough level.", 
                "intervention_name": "A) TEST", 
                "intervention_type": "Drug", 
                "other_name": "1. Test group : Extended Release Tacrolimus (Advagraf\u00ae) + Sirolimus (Rapamune\u00ae)"
            }, 
            {
                "arm_group_label": [
                    "A) TEST", 
                    "B) CONTROL"
                ], 
                "description": "Extended Release Tacrolimus (Advagraf\u00ae)\n: Same as above.\nMycophenolate mofetil : After surgery : 500mg/kg po. within 24hrs after reperfusion. After that, daily dose: 1000mg bid", 
                "intervention_name": "B) CONTROL", 
                "intervention_type": "Drug", 
                "other_name": "2. Control group: Extended Release Tacrolimus (Advagraf\u00ae) + Mycophenolate mofetil"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Mycophenolate mofetil", 
                "Sirolimus", 
                "Everolimus", 
                "Tacrolimus", 
                "Mycophenolic Acid"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "RECORD study", 
        "lastchanged_date": "August 12, 2013", 
        "location": [
            {
                "contact": {
                    "email": "dr.ohchangkwon@gmail.com", 
                    "last_name": "Chang Kwon Oh, MD", 
                    "phone": "82-31-219-5758"
                }, 
                "facility": {
                    "address": {
                        "city": "Suwon", 
                        "country": "Korea, Republic of", 
                        "state": "KyungKi Province"
                    }, 
                    "name": "Ajou Univeristy Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "drcdkim@knu.ac.kr", 
                    "last_name": "Chan Duck Kim", 
                    "phone": "053-420-5560"
                }, 
                "facility": {
                    "address": {
                        "city": "Daegu", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Kyungpook national hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "yukim@yuhs.ac", 
                    "last_name": "Yu Seun Kim, MD, PhD", 
                    "phone": "82-2228-2115"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "120-752"
                    }, 
                    "name": "Severance hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mkju@yuhs.ac", 
                    "last_name": "Man Ki Ju", 
                    "phone": "02-2019-3893"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Gangnam Severance hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jwhamd@snu.ac.kr", 
                    "last_name": "JongWon Ha, MD", 
                    "phone": "82-2-2072-2991"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Seoul National University hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "cheolwoongjung@gmail.com", 
                    "last_name": "Cheol Woong Jung, MD", 
                    "phone": "82-2-920-6858"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Korea University Anam Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "hrcho@uuh.ulsan.kr", 
                    "last_name": "Hong Rae Cho", 
                    "phone": "052-250-7004"
                }, 
                "facility": {
                    "address": {
                        "city": "Ulsan", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Ulsan Univ Hospital"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "smile@yuhs.ac", 
            "last_name": "YU SEUN KIM, MD", 
            "phone": "+82 2 2228 0453"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Biopsy confirmed acute rejection\nSubjects and graft survival\nGlomerular filtration rate (GFR)\n24-hour urine test results at 12 months after kidney transplant: Urine protein, CrCl.", 
            "measure": "Failure rate in effectiveness of up to 12 months after kidney transplant", 
            "safety_issue": "No", 
            "time_frame": "12 months after kidney transplant"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01680952"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Yonsei University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yonsei University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}